Rare diseases
Investigational molecules
Locations
Back to Spain115 clinical trials in Badajoz, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments
SpainStudy on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension
SpainPhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
SpainStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
SpainStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
SpainStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
SpainStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
SpainStudy on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine
SpainStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
SpainStudy of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer
SpainGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
SpainEvaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on breast cancer treatments, including studies for HER2-positive, triple-negative, and hormone receptor-positive variants. Additional research explores novel therapies for bladder cancer and prostate cancer.
Studies evaluate combination therapies and novel drug applications for improved patient outcomes.
Innovative research targeting Type 1 Diabetes and obesity management. Studies investigate new therapeutic approaches for weight management and glycemic control in patients with multiple metabolic conditions.
Focus on developing integrated treatment approaches for complex metabolic conditions.
Comprehensive research into systemic lupus erythematosus and psoriatic arthritis, evaluating new therapeutic agents and treatment approaches for chronic autoimmune conditions.
Trials aim to improve long-term disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
